Related Experiment Video
Updated: May 3, 2026
08:30
Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
Published on: March 12, 2016
12.7K
[Glaucoma therapy - current overview of data and information]
Summary
This study reviews current glaucoma therapy, focusing on medication management, generic drug roles, and treatment costs. It provides insights into financial and legal aspects of glaucoma care for healthcare professionals.
Area of Science:
- Ophthalmology
- Pharmacoeconomics
Background:
- Glaucoma therapy involves complex medication management and surgical interventions.
- Understanding the financial and legal landscape is crucial for effective patient care.
Purpose of the Study:
- To provide an overview of current glaucoma treatment trends.
- To analyze the financial aspects of both medicament and surgical glaucoma treatments.
- To clarify the role of generic drugs and associated costs.
Main Methods:
- Review of current antiglaucomatic drugs and their management.
- Analysis of financial data including patient supplementary payments and surgical costs.
- Inclusion of pharmacologists' and regulatory authority (SÚKL) viewpoints.
Main Results:
- Detailed examination of available antiglaucomatic medications and their positioning.
- Analysis of benzalkonium chloride dosage and patient out-of-pocket expenses.
- Comparison of costs associated with medicament and surgical glaucoma treatments.
Conclusions:
- The study offers a comprehensive guide to glaucoma therapy, integrating clinical, financial, and legal considerations.
- It aims to orient healthcare professionals on the current state of glaucoma treatment and associated expenditures.
- Insights into drug management, generic drug utility, and cost-effectiveness are provided.
Related Concept Videos
01:25Glaucoma: Overview
1.7K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.7K
01:27Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
01:28Angle Closure Glaucoma: Treatment
1.6K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.6K
01:23Ophthalmic Drug Delivery Systems
283
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
283